Heinz Bülzebruck
Heinz Bülzebruck publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations and Medical Imaging and Pathology Studies.
- World rank
- #5,192,129 of 7,710,434 ranked researchers
- Rank in Germany
- #268,476 of 364,343
- Works
- 43
- Citations
- 573
- Citations per work
- 13.3
What does Heinz Bülzebruck research?
Heinz Bülzebruck's work is mostly in Medicine (85%), Biochemistry, Genetics and Molecular Biology (4%), Immunology and Microbiology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3785.2%
- Medicine3785.2%
- Everything else49.2%
- Life Sciences25.6%
- 1Pulmonary and Respiratory Medicine61% of their works
- 2Oncology18% of their works
- 3Radiology, Nuclear Medicine and Imaging4% of their works
- 4Cancer Research4% of their works
- 5Pathology and Forensic Medicine3% of their works
- 6Immunology2% of their works
Research topics
Which keywords describe Heinz Bülzebruck's research?
The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, ALK Inhibitors, CT Screening, EGFR Mutations, Lung Cancer and Metastasis.
- Malignant Pleural Mesothelioma
- BAP1 mutations
- Lung Tumors
- Genomic Profiles
- Cancer of Unknown Primary
- Pulmonary Sclerosing Hemangioma
- Molecular Profiling
- Metastasis
- EGFR Mutations
- ALK Inhibitors
- Clinical Trials
- Chemotherapy
- Targeted Therapy
- CT Screening
- Lung Cancer
- Immunohistochemistry
- Pulmonary Alveolar Microlithiasis
- Immunotherapy
- Tissue of Origin
- Small-Cell Lung Cancer
- Metastatic Carcinomas
- Empyema
- Pleural Effusion
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Chemotherapy222 topics
- Clinical Trials222 topics
- Targeted Therapy222 topics
- ALK Inhibitors161 topic
- CT Screening161 topic
- EGFR Mutations161 topic
- Lung Cancer161 topic
- Metastasis142 topics
- Immunohistochemistry132 topics
- Molecular Profiling132 topics
- Pulmonary Alveolar Microlithiasis121 topic
- Pulmonary Sclerosing Hemangioma121 topic
- Immunotherapy102 topics
- Cancer of Unknown Primary81 topic
- Tissue of Origin81 topic
- Genomic Profiles61 topic
- Small-Cell Lung Cancer61 topic
- Lung Tumors51 topic
- Metastatic Carcinomas51 topic
- BAP1 mutations41 topic
- Empyema41 topic
- Malignant Pleural Mesothelioma41 topic
- Pleural Effusion41 topic
Where does Heinz Bülzebruck work?
Heinz Bülzebruck's main affiliation in the publication record is Frauenklinik Heidelberg, Germany.
How many publications and citations does Heinz Bülzebruck have?
OpenAlex counts 43 works and 573 citations for Heinz Bülzebruck, an h-index of 11, ranking #5,192,129 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Heinz Bülzebruck. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.